Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2023 – Feb 2025Where it's discussed
-
X / Twitter16 posts
-
YouTube2 videos
AI synopsis
What people are saying
The overall tone reflects dismissive and mostly negative sentiments, exemplified by phrases like 'propaganda,' questions about whether these medications are merely 'another plaster,' and comments calling weight loss strategies 'dangerous,' which reveal a lack of appreciation for the research's potential impact. The use of sarcastic and critical language indicates an orientation toward criticizing rather than engaging with the scientific findings.
Most posts express skepticism or outright criticism, indicating disagreement with the study or its implications.
Discussions show low curiosity, mainly dismissing or mocking the research rather than engaging deeply.
Posts mostly share brief opinions or skepticism, with minimal detailed discussion or analysis.
The tone suggests limited recognition of the study’s scientific importance, viewing it more as a subject for debate or ridicule.
Abstract in brief
- GLP-1, a gut-derived peptide, promotes the differentiation of preadipocytes into adipocytes by increasing specific protein and gene expressions related to fat cell development, such as aP2, PPAR, CEBP, and LPL.
- The study found that while GLP-1 enhances the formation of small adipocytes and activates the Akt signaling pathway during early differentiation, it does not significantly increase overall lipid accumulation in these cells.
- These findings suggest that GLP-1 influences adipogenesis and may produce small, potentially more insulin-sensitive adipocytes, which could positively impact insulin resistance and obesity management.]
Top posts
Most liked on X and Blueskyhttps://t.co/Y7x0UZpsoU
Oh, this is comedy gold! https://t.co/xEHq0KrIpT
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
All mentions
Risks of Ozempic for Weight Loss and Fat Cell Effects
Dr. Shawn Baker discusses the potential dangers of Ozempic, including dramatic early weight loss, fat cell multiplication, and concerns related to weight management methods like Weight Watchers.
Understanding the Impact of GLP-1 on Fat Cell Development and Metabolism
CherylNoSugarCoach discusses the complex science behind Ozempic and GLP1 drugs, highlighting their influence on fat cell differentiation and potential benefits for insulin sensitivity and obesity management, based on…
@Carlsbergfondet @SorenSchifter Til borgere som falder for propagandaen, så lyt her og overvej om disse medikamenter nu blot er endnu et plaster, som afholder dig fra et VARIGT vægttab Kan din læge vejlede dig til et VARIGT vægttab!? NEJ!! Det kan din læge ikke, desværre
6 Reasons Ozempic Weight Loss IS DANGEROUS https://t.co/i9iQwYEinf
6 Reasons Ozempic Weight Loss IS DANGEROUS https://t.co/j0qX7Jbakl via @YouTube
6 Reasons Ozempic Weight Loss IS DANGEROUS https://t.co/bnsj16MEhO via @YouTube
Oh, this is comedy gold! https://t.co/xEHq0KrIpT
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: https://t.co/Y7x0UZpsoU
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: https://t.co/Y7x0UZpsoU
RT @SBakerMD: Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
Want more research around GLP-1 and adipogenesis? Here you go: https://t.co/Y7x0UZoUzm
RT @SBakerMD: https://t.co/Y7x0UZpsoU
@ShivenChabria @SBakerMD Here’s the paper he is referencing. https://t.co/45sy6JUGdz
https://t.co/Y7x0UZpsoU
DB
MI
D
AM
P
D
KE
S
TT
MJ